Try Ageless Review: Three Routes, and Three Prices for One Vial

The short version

Try Ageless sells compounded sermorelin three ways — a 15 mg injection at $189 a month, a 600 mcg sublingual troche at $149 and a 1000 mcg/mL nasal spray at $149 for a 6 mL bottle — which makes it the only one of the 33 providers we track that publishes all three routes with a strength printed beside each. That breadth is real, the doses are named, and the company names both the pharmacy that dispenses and the physician who signs.

Then there is the price, and the price is a mess. On 29 August 2026 the same 15 mg vial carried four different figures across the company's own pages — $126, $189, $239–$289 and $239 — depending on which page, and which part of which page, you read. The $176 usually quoted for this company is none of them. It survives in one place only: as $1,056 divided by six, the per-month equivalent of the six-month prepayment.

And one thing the sales pages do not say at all: the assessment is advertised as free five times, but the Terms set a $40 clinical consultation fee that is earned and non-refundable "regardless of the clinical outcome, including where a Provider decides that treatment or a prescription is not appropriate." If a clinician turns you down, you are out $40. Two of the providers we rank ahead of it refund you in full in that situation.

Four prices, one vial

The reconciliation is not hard once you see where each number is stored. The category listing and the product page's own listing data both come from the store's price fields, and both say $239 regular, $189 on sale. The specification table agrees on the $239, and so does the plans page, which sells "1-Pack (Monthly) $239 · billed monthly". The odd one out is a hand-built headline block at the top of the product page reading $126 beside a struck-through $176 — static markup the rest of the page has moved past. Four surfaces to one, and the four agree.

So treat $189 a month as the figure to plan around for the injection, and be ready to see $239. The troche and the nasal spray have no such problem: $149 against a struck-through $199 on the product page, the listing, the specification table and the listing data alike.

The multi-month ladder is only published on the plans page. For the injection it runs $239 monthly, $567 a quarter (about $189 a month), and $1,056 for six months (about $176 a month); the troche runs $199, $537 a quarter, $954 for six. The $50 code takes fifty dollars off once, not every month, and the page is unusually blunt about the mechanics: "Click SERM50 to copy — discount is not automatic" and "Enter SERM50 manually at checkout." The nasal spray uses a different code again, FIRST50, printed on its own product page. Worth knowing before you assume one code covers the range.

Two more things about that plans page. It does not sell the nasal spray at all, so a reader who arrives there never learns the third route exists. And its plan buttons do not carry a plan: all nine calls to action on the page resolve to the same single intake URL, so nothing you click selects the tier you just read about. The prices are a display, not a choice, and the product pages say what actually settles the amount — "Exact pricing depends on your prescribed dose. Final amount is shown after clinical review."

The free assessment, and the $40

The plans page says "START MY FREE ASSESSMENT" twice, lists "Online medical assessment — Free" among the inclusions, and closes with a checklist item reading "Free assessment." The Terms of Use, last updated 20 August 2026, say something else in section 8.2: a $40 clinical consultation fee for all non-TRT services — sermorelin is non-TRT — "earned and non-refundable once the Provider consultation or clinical review begins or is completed," applying "regardless of the clinical outcome, including where a Provider decides that treatment or a prescription is not appropriate." The TRT equivalent is $55. Miss a scheduled consultation and the fee applies too.

You can read the two as compatible: the questionnaire is free, the clinician's time is not. But a reader who takes a free assessment and gets declined will not feel that they were told. It is the difference between this company and the two we rank above it, both of which return your money in full if a clinician says no.

Section 8 holds a second clause worth reading before you buy a discounted block. Multi-month discounts are conditional on finishing the term. Stop early and the months you already received are re-priced upward at the shorter-plan or month-to-month rate, with the term-dependent promotion stripped out. Apply that to the six-month injection block: you paid $1,056 at an advertised $176 a month, and the single month you took back out is charged at $239, with the $40 fee and 2.9–4.9% of non-recoverable card processing deducted on top. That is not a cancellation penalty by name, and the plans page is accurate to say there are no cancellation fees — but it is a clawback by arithmetic, and it lives four clicks away in a collapsed panel. Section 8.3 tightens it further: once a prescription has gone to the pharmacy or shipped, the medication is not refundable at all.

To its credit, that section is unusually complete: it shows how refunds are calculated, deducts processing at a stated percentage rather than a vague fee, promises refunds within ten business days, and requires plan term, total price and billing cadence to be shown before purchase. Most companies here publish nothing this specific. It is the mismatch with the marketing, not the policy, that costs them.

Who fills it, and who signs it

Try Ageless names both, which puts it ahead of most of what we rank.

The dispensing pharmacy is Pharmacy Hub, 15600 NW 15th Ave Suite C, Miami, Florida, (888) 958-1382, named on the medical oversight page and repeated in the safety information, the privacy policy and the Terms. The prescriber is Wasef Health, PC, under the medical direction of Michael Wasef, MD, NPI 1417261926 — and that NPI checks out: the federal registry returns an active listing for Michael Wasef, MD, internal medicine, Florida license ME125730, at the Pinellas Park address the company publishes. The Terms add something rarer still: you may use your own pharmacy instead, by asking for a prescription transfer during the consultation.

Two qualifiers. The disclosure is thinner than it looks, because Pharmacy Hub is a shared bench — Pallas Health names it as one of six partners and Willow as one of three — so it describes the network your prescription passes through rather than anything exclusive here. And there is no list of states. The oversight page has a heading for it, then says only that availability is "confirmed during consultation"; the FAQ says shipping goes to "eligible U.S. locations where service is available." If your state matters, ask before you pay the $40.

Smaller inconsistencies, while you are in the fine print. The contact page publishes (310) 361-7849 and the oversight page +1 (302) 440-4386 — two numbers for one company. The Terms and privacy policy call the operator Lovely Ageless Group; the oversight page and the plans-page footer call it Lovely Meds, Inc. And two pages still carry their own drafting notes in public, the Terms printing "If your site uses different page slugs, update the links above once."

The plans page furniture deserves the same flat treatment. Its countdown clock is a per-visit timer written into the page — the source comment says so — so "Ends in 23h 59m" restarts on every load and never expires, and the scrolling feed of people supposedly starting treatment is nine fixed lines of markup on a loop, one of them reading "9 minutes ago" since the day it was written. Neither changes what the medicine is. Both tell you what the page is for.

The FDA warning letter

The FDA issued a warning letter to Lovely Meds, Inc. dba Lovely Meds in September 2025. Lovely Meds, Inc. is the entity Try Ageless itself names as the operator of tryageless.com, on its own medical oversight page and in the footer of the sermorelin page we link to, so the letter belongs to the company you would be buying from. We confirmed it on 29 August 2026 against the agency's own index, which you can search yourself in the [FDA warning-letter database](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) by that addressee.

What the letter says is the agency's to state, not ours to paraphrase, so we do not. A letter does not change where this company sits on our ranking or whether we are paid for a click to it, and you should know both of those at once — our methodology explains how placement is decided.

One related claim we will not repeat either way: the site displays a LegitScript seal. LegitScript's own checker asks you to clear a captcha before it will answer, so we cannot confirm the certification from outside, and we are not going to pass it along as verified.

Does sermorelin justify any of these numbers?

Sermorelin is a synthetic copy of the first 29 amino acids of growth-hormone-releasing hormone. It does not supply growth hormone; it prompts your own pituitary to release more of it⁵, which is why it is dosed at night and why the best-supported effects are on sleep and the GH/IGF-1 axis. Nightly GHRH(1-29) raised GH and IGF-1 in healthy older men in a controlled study⁶; the wider literature on augmenting growth hormone in healthy adults finds small body-composition changes, no functional gain and a real side-effect rate⁹. Our evidence review grades each claim.

That evidence was built on the injected route, which is how sermorelin has been characterized since its clinical use began⁷, and Try Ageless says as much itself when it calls the injection the format with "highest bioavailability and most clinical evidence." For the troche and the spray it publishes no bioavailability figure at all — not on the product pages, not in the specification tables, not on the plans page. The convenience is genuine; what a needle-free route costs you in absorbed drug is the question the company does not answer, and it is the right one to ask about a $149 month. Compounded sermorelin is not an FDA-approved product in any route either; no compounded drug is reviewed for safety or efficacy before dispensing⁸, and this company says so plainly, which many do not.

Verdict

Try Ageless gives you more real information than most of what we rank — three routes with named strengths, a named pharmacy with a street address and a phone number, a named physician whose registration you can check in a minute, an option to use your own pharmacy, and a refund policy written with actual numbers in it. That is a better disclosure record than its price presentation deserves.

Buy it with your eyes open on two points. The injection is $189 a month, not the $126 or $176 you will see quoted, and if you meet a $239 at checkout the company's own listing data says that is the regular price rather than a mistake. And the free assessment stops being free the moment a clinician reads it — $40, kept whether or not you are approved, disclosed only inside a collapsed panel in the Terms. If a prepaid block tempts you, read section 8.5 first; leaving early re-prices the months you took at the undiscounted rate.

If you want the format choice, this is the one place on our ranking that offers all three. If you want a number you can trust before you pay, our price-sorted list shows who publishes one figure and stands behind it.